Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 3Recurrence 2Pleural Effusion, Malignant 2Mesothelioma, Malignant 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1NSCLC 1Myeloproliferative Disorders 1Multiple Myeloma 1Melanoma 1Lymphoma 1Lymphedema 1Leukemia, Myeloid, Chronic-Phase 1Immunoglobulin Light-chain Amyloidosis 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Glioblastoma 1Fibrosis 1Fallopian Tube Neoplasms 1Dysplastic Nevus Syndrome 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

asciminib 8Dasatinib 7nilotinib 6Imatinib Mesylate 5Cyclophosphamide 4ponatinib 3fludarabine phosphate 3bosutinib 3Whole-Body Irradiation 3ruxolitinib 2letermovir 2Tacrolimus 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Melphalan 2Cyclosporine 2Busulfan 2venetoclax 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1decitabine and cedazuridine drug combination 1Vorinostat 1Valganciclovir 1Tyrosine Kinase Inhibitors 1Therapeutics 1Stem Cell Transplantation 1Sirolimus 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Chronic-Phase × Pharmaceutical Preparations × 1 year × Clear all
NCT03817398 2026-05-20

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Children's Oncology Group

Phase 2 Active not recruiting
110 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡